Webinar: A revolutionary approach to aid in the diagnosis of serious and complex infections
mcfDNA METAGENOMIC SEQUENCING: A DEEPER LEVEL OF DETECTION FOR DIFFICULT TO DIAGNOSE PATHOGENS
Learn how metagenomic sequencing of microbial cell-free DNA (mcfDNA) has emerged as a precision technique to quickly and accurately diagnose serious and complex infections — which is particularly important in immunocompromised patients.
This webinar will provide participants with an overview of mcfDNA metagenomic sequencing assays, including plasma and bronchoalveolar lavage fluid (BALF) testing, offered in collaboration with Karius. Participants will also learn about clinical decision-making around test ordering, appropriate clinical indications, and how to interpret and apply results to support timely diagnosis and patient management.
Learning objectives
Upon completion of this activity, participants should be able to:
- Describe the role of mcfDNA metagenomic sequencing in the diagnosis of serious and complex infections, particularly in immunocompromised patients.
- Identify appropriate clinical scenarios for ordering metagenomic testing.
- Interpret metagenomic test results and apply them to support timely diagnosis and patient management.
SAVE THE DATE:
OCT. 9, 2026
Intended audience
Infectious disease physicians, hospitalists, intensivists, transplant physicians, hematology/oncology physicians, clinical microbiologists, pathologists, advanced practice providers (NPs and PAs), pharmacists, and other healthcare professionals involved in the diagnosis and management of serious infections, particularly in immunocompromised patients.
Presenters
Chief Scientific Officer for Mayo Clinic Laboratories
Bio
Dr. Binnicker is the chief scientific officer of Mayo Clinic Laboratories, has served as the director of the Clinical Virology and Clinical Microbiology Molecular Laboratories, and is a professor of laboratory medicine and pathology at Mayo Clinic. As chief scientific officer, Dr. Binnicker spearheads the scientific endeavors of Mayo Clinic Laboratories and leads product research, design, and development initiatives. He also works closely with leaders in Mayo Clinic's Department of Laboratory Medicine and Pathology, with other independent clinical laboratories, and with leading diagnostic manufacturers to provide advanced testing and pathology services for healthcare organizations.
Associate Professor of Medicine and infectious disease specialist at Mayo Clinic
Bio
As an infectious disease specialist in the Division of Infectious Diseases at Mayo Clinic, Dr. Abu Saleh is both a practicing clinician and researcher focused on infectious disease pathology, including the role of metagenomic sequencing in diagnosing patients with serious systemic infections.
Questions
Contact us at mcleducation@mayo.edu for more information.